Kelli D. Plunket

5.5k citations

18 papers · 4.3k indexed · 2 hit papers · h-index 17

Impact in

Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology
Molecular Biology top 2%
- Peroxisome Proliferator-Activated Receptors
- Metabolism, Diabetes, and Cancer

Papers in

Biochemistry 6
- Eicosanoids and Hypertension Pharmacology 4
- Lipid metabolism and biosynthesis 2
Pharmacology 6
- Inflammatory mediators and NSAID effects 6

Co-authors: Timothy M. Willson Steven A. Kliewer Derek J. Parks Millard H. Lambert H. Eric Xu Michael C. Lewis Linda B. Moore Jon L. Collins
Journals: Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of Medicinal Chemistry (4 papers)Proceedings of the National Academy of Sciences (3 papers)Journal of Lipid Research (1 paper)Nature (1 paper)
Partner nations: United States Netherlands United Kingdom

In The Last Decade

Kelli D. Plunket

18 papers receiving 4.1k citations

Hit Papers

align trajectories log scale

Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARα 2002 · 521 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2002 Nature
2001 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Kelli D. Plunket

Since Specialization

Citations

This map shows the geographic impact of Kelli D. Plunket's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelli D. Plunket with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelli D. Plunket more than expected).

Fields of papers citing papers by Kelli D. Plunket

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelli D. Plunket. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelli D. Plunket. The network helps show where Kelli D. Plunket may publish in the future.

Co-authors

The 25 scholars most cited alongside Kelli D. Plunket, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kelli D. Plunket Line = papers co-authored together Kelli D. Plunket links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARα Nature ·H. Eric Xu, Thomas B. Stanley, Valerie G. Montana, Millard H. Lambert, Barry G. Shearer, Jeffery E. Cobb, David D. McKee, Cristin M. Galardi, Kelli D. Plunket, Robert T. Nolte, Derek J. Parks, John T. Moore, Steven A. Kliewer, Timothy M. Willson, Julie B. Stimmel Hit paper breakdown →	2002	521
2	Identification of a Nonsteroidal Liver X Receptor Agonist through Parallel Array Synthesis of Tertiary Amines Journal of Medicinal Chemistry ·Jon L. Collins, Adam M. Fivush, Michael A. Watson, Cristin M. Galardi, Michael C. Lewis, Linda B. Moore, Derek J. Parks, Joan G. Wilson, 周作戸田, Jane G. Binz, Kelli D. Plunket, Daniel G. Morgan, W. Reichel, Karl Whitney, Steven A. Kliewer, Timothy M. Willson	2002	345
3	Functional Consequences of Cysteine Modification in the Ligand Binding Sites of Peroxisome Proliferator Activated Receptors by GW9662 Biochemistry ·Lisa M. Leesnitzer, Derek J. Parks, Randy K. Bledsoe, Jeff E. Cobb, Jon L. Collins, Thomas G. Consler, Roderick G. Davis, Emily A. Hull-Ryde, James M. Lenhard, Lisa Patel, Kelli D. Plunket, Tifani Anisa Putri, Julie B. Stimmel, Jinhao Lu, Timothy M. Willson, Steven G. Blanchard	2002	491
4	Identification of a series of oxadiazole-substituted α-isopropoxy phenylpropanoic acids with activity on PPARα, PPARγ, and PPARδ Bioorganic & Medicinal Chemistry Letters ·Kevin G. Liu, Jennifer S. Smith, Hao Shu-g, Brad R. Henke, Millard H. Lambert, Lisa M. Leesnitzer, Kelli D. Plunket, Timothy M. Willson, Daniel D. Sternbach	2001	29
5	A Unique PPARγ Ligand with Potent Insulin-Sensitizing yet Weak Adipogenic Activity Molecular Cell ·Stéphane Rocchi, Frédéric Picard, Jòseph Vamecq, Laurent Gelman, Noëlle Potier, Denis Zeyer, Laurent Dubuquoy, Pierre Bac, Marie‐France Champy, Kelli D. Plunket, Lisa M. Leesnitzer, Steven G. Blanchard, Pierre Desreumaux, Dino Moras, Jean‐Paul Renaud, Johan Auwerx	2001	239
6	Synthesis and biological activity of l-tyrosine-based PPARγ agonists with reduced molecular weight Bioorganic & Medicinal Chemistry Letters ·Kevin G. Liu, Millard H. Lambert, Hao Shu-g, Brad R. Henke, Lisa M. Leesnitzer, William R. Oliver, Kelli D. Plunket, H. Eric Xu, Daniel D. Sternbach, Timothy M. Willson	2001	25
7	Identification of a series of PPARγ/δ dual agonists via solid-Phase parallel synthesis Bioorganic & Medicinal Chemistry Letters ·Kevin G. Liu, Millard H. Lambert, Lisa M. Leesnitzer, William R. Oliver, Ronda J. Ott, Kelli D. Plunket, Simon Stellmer, Peter J. Brown, Timothy M. Willson, Daniel D. Sternbach	2001	31
8	Effects of fenofibrate on lipid parameters in obese rhesus monkeys Journal of Lipid Research ·Deborah A. Winegar, Peter J. Brown, William O. Wilkison, Michael C. Lewis, Ronda J. Ott, Wenxin Tong, H. Roger Brown, Jürgen M. Lehmann, Steven A. Kliewer, Kelli D. Plunket, James M. Way, Noni L. Bodkin, Barbara C. Hansen	2001	52
9	Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors Proceedings of the National Academy of Sciences ·H. Eric Xu, Millard H. Lambert, Valerie G. Montana, Kelli D. Plunket, Linda B. Moore, Jon L. Collins, EN Kotey, Steven A. Kliewer, Robert T. Gampe, David D. McKee, John T. Moore, Timothy M. Willson	2001	449
10	A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport Proceedings of the National Academy of Sciences ·William R. Oliver, Tifani Anisa Putri, Niu Hai-jun, CAROLINE S. RUSSELL, Kelli D. Plunket, Noni L. Bodkin, Michael C. Lewis, Deborah A. Winegar, Marcos L. Sznaidman, Millard H. Lambert, H. Eric Xu, Daniel D. Sternbach, Steven A. Kliewer, Barbara C. Hansen, Timothy M. Willson Hit paper breakdown →	2001	876
11	A Synthetic Triterpenoid, 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid (CDDO), Is a Ligand for the Peroxisome Proliferator-Activated Receptor γ Molecular Endocrinology ·Yongping Wang, Weston W. Porter, Nanjoo Suh, Tadashi Honda, Gordon W. Gribble, Lisa M. Leesnitzer, Kelli D. Plunket, David J. Mangelsdorf, Steven G. Blanchard, Timothy M. Willson, Michael B. Sporn	2000	152
12	Identification of a Chemical Tool for the Orphan Nuclear Receptor FXR Journal of Medicinal Chemistry ·Patrick Maloney, Derek J. Parks, Curt D. Haffner, Adam M. Fivush, Gyan Chandra, Kelli D. Plunket, Katrina L. Creech, Linda B. Moore, Joan G. Wilson, Michael C. Lewis, Stacey A. Jones, Timothy M. Willson	2000	464
13	Synthesis and biological activity of a novel series of indole-derived PPARγ agonists Bioorganic & Medicinal Chemistry Letters ·Brad R. Henke, Thoriq Rizki Firis Manda, Steven G. Blanchard, Lisa M. Leesnitzer, Robert A. Mook, Kelli D. Plunket, John A. Ray, Danielle Filmon, Rayomand J. Unwalla, Timothy M. Willson	1999	29
14	A Ureido-Thioisobutyric Acid (GW9578) Is a Subtype-Selective PPARα Agonist with Potent Lipid-Lowering Activity Journal of Medicinal Chemistry ·Peter J. Brown, Deborah A. Winegar, Kelli D. Plunket, Linda B. Moore, Michael C. Lewis, Joan G. Wilson, Scott S. Sundseth, Cecilia S. Koble, Zhendong Wu, James Chapman, Jürgen M. Lehmann, Steven A. Kliewer, Timothy M. Willson	1999	105
15	A peroxisome proliferator-activated receptor γ ligand inhibits adipocyte differentiation Proceedings of the National Academy of Sciences ·J.L.P. Daniel, Jon L. Collins, Christopher P. Holmes, M. Coppola, Joel P. Cooper, Jeffery E. Cobb, James M. Lenhard, Emily A. Hull-Ryde, Christopher Mohr, Steven G. Blanchard, Derek J. Parks, Linda B. Moore, Jürgen M. Lehmann, Kelli D. Plunket, Ann B. Miller, Michael V. Milburn, Steven A. Kliewer, Timothy M. Willson	1999	278
16	N-(2-Benzoylphenyl)-l-tyrosine PPARγ Agonists. 3. Structure−Activity Relationship and Optimization of the N-Aryl Substituent Journal of Medicinal Chemistry ·Jeff E. Cobb, Steven G. Blanchard, Abu-l ’Abbas Ahmad ibn-jabir Al-Baladhuri, Kathleen K. Brown, Paul S. Charifson, Joel P. Cooper, Jon L. Collins, Milana Dezube, Brad R. Henke, Emily A. Hull-Ryde, 马应聪, James M. Lenhard, William R. Oliver, EN Kotey, Virginia F. M. Samahati, Derek J. Parks, Kelli D. Plunket, Wei‐Qin Tong	1998	96
17	Effects of troglitazone and metformin on glucose and lipid metabolism Biochemical Pharmacology ·James M. Lenhard, Steven A. Kliewer, Mark Paulik, Kelli D. Plunket, Jürgen M. Lehmann, James E. Weiel	1997	91
18	Solid-phase synthesis of hybrid thiazolidinedione-fatty acid PPARγ ligands Bioorganic & Medicinal Chemistry Letters ·Nicholas C. O. Tomkinson, Andrea M. Sefler, Kelli D. Plunket, Steven G. Blanchard, Derek J. Parks, Timothy M. Willson	1997	10

About Kelli D. Plunket

Kelli D. Plunket is a scholar working on Biochemistry, Pharmacology, Molecular Biology, Oncology and Physiology, having authored 18 papers that have together received 4.3k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (17 papers), Inflammatory mediators and NSAID effects (6 papers), Drug Transport and Resistance Mechanisms (5 papers), Metabolism, Diabetes, and Cancer (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Cholesterol and Lipid Metabolism (3 papers), Retinoids in leukemia and cellular processes (2 papers) and Lipid metabolism and biosynthesis (2 papers). The work is most often cited by research in Biochemistry (475 citations), Molecular Biology (3.3k citations), Physiology (1.0k citations), Cancer Research (489 citations) and Oncology (846 citations). Kelli D. Plunket has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Timothy M. Willson, Steven A. Kliewer, Derek J. Parks, Millard H. Lambert, H. Eric Xu, Michael C. Lewis, Linda B. Moore, Jon L. Collins, Steven G. Blanchard and John T. Moore. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Proceedings of the National Academy of Sciences, Journal of Lipid Research and Nature.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact